Clinical trial

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

NCT02506790

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Melatonin Normalized identity: melatoninView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Toremifene Normalized identity: toremifeneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-07-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

metforminDRUG · verified · RxNorm: metformin

MelatoninDRUG · verified · RxNorm: melatonin

ToremifeneDRUG · verified · RxNorm: toremifene

Sponsors & collaborators

N.N. Petrov National Medical Research Center of Oncologylead sponsor

Mapped research locations

Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02506790 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.